Zhende Medical Co., Ltd. Zhende Medical Co., Ltd. (603301.SS) is a China-based company principally engaged in the research, development, production, and sales of medical dressings and related healthcare products; its core offerings encompass modern wound care products including advanced dressings, stoma care solutions, and bioactive materials; traditional wound care items such as gauze swabs, bandages, non-woven swabs, and lap sponges; pressure treatment and fixation products like compression wraps and immobilization devices; surgical infection management solutions including surgical drapes, gowns, and infection control kits; sensory control protection and incontinence care products; as well as medical-grade personal care, home health care, and sports protection items. Founded in 1993 and headquartered in Shaoxing City, Zhejiang Province, the company operates five manufacturing bases across Zhejiang, Henan, Jiangsu, Anhui, and Shanghai, with distribution networks covering 31 provinces in China and exports to over 73 countries primarily in Europe and North America, serving nearly 10,000 hospitals, health systems, and over 40,000 pharmacies. Zhende Medical holds certifications including FDA, CE, ISO 13485, and CFDA, positioning it as a market leader in infection control, compression therapy, and wound care segments in China. Recent developments include the April 2023 acquisition of Jiangsu Embrace Science & Technology Development Co., Ltd. to expand prefilled syringe and related product capabilities; a March 2025 stake transaction where Sun Jimu acquired a 5% interest from Zhejiang Zhende Holding Co., Ltd.; property sale announced in September 2024 for 298 million yuan to optimize assets; and participation in the 2025 China International Medical Equipment Fair (CMEF) to showcase next-generation innovations in pressure testing and medical solutions.